🇺🇸 FDA
Patent

US 7368435

Topical endoparasiticide and ectoparasiticide formulations

granted A61PA61P33/00A61P33/10

Quick answer

US patent 7368435 (Topical endoparasiticide and ectoparasiticide formulations) held by Summit VetPharm, LLC expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Summit VetPharm, LLC
Grant date
Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P33/00, A61P33/10, A61P33/14